Anonymous ID: 744b4d Dec. 4, 2021, 8:48 a.m. No.15134447   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>4484 >>4537 >>4676 >>4826 >>4912

Scientists believe they have found the trigger for the rare blood clots in people who have taken the Oxford/AstraZeneca COVID-19 vaccine.

 

A study by a team of researchers from the United States and United Kingdom found a protein in the blood โ€” known as platelet factor 4 (PF4) โ€” that reacts to the adenovirus used by the vaccine that then causes a chain reaction involving the immune system.

 

This reaction can result in the dangerous clots โ€” a condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT), or Thrombosis with Thrombocytopenia (TTS).

 

"These data confirm that PF4 is capable of forming stable complexes with clinically relevant adenoviruses, an important step in unraveling the mechanisms underlying TTS," said an abstract of the study, conducted by researchers at Arizona State University, Cardiff University in Wales, and other institutions.

 

An AstraZeneca spokesperson said that although the research is not definitive, it offers interesting insights, and AstraZeneca is exploring ways to leverage these findings in its efforts to remove the rare side effect.

 

"This pre-clinical research further advances our knowledge about the potential mechanisms underlying the extremely rare condition, Thrombosis with Thrombocytopenia (TTS), which is treatable for the majority of people," the spokesperson said in a statement to The Hill.

 

"It is important to note that the mechanism identified does not demonstrate that it is the cause of TTS and that most individuals that will have PF4 antibodies will not develop TTS," the spokesperson added.

 

The spokesperson noted there is a significantly higher likelihood of developing TTS if a person is unvaccinated and develops COVID-19, than if vaccinated with the AstraZeneca vaccine.

 

AstraZeneca's vaccine has not been authorized to be administered in the U.S., although the company has agreed to supply 700,000 doses once an emergency use authorization is granted.

 

https://thehill.com/policy/healthcare/public-global-health/584017-scientists-find-trigger-for-rare-blood-clots-in?fbclid=IwAR2GPiamW8hvWyyhXP5yQH3Ippn0-VXL0hIQM4fzOkGaj5qM52Tp0kRBzoE

Anonymous ID: 744b4d Dec. 4, 2021, 8:50 a.m. No.15134461   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>4898

Now it's Glass particles in the poison vaxxx

 

Gilead is recalling vials of Remdesivir, a drug used for treating coronavirus patients, due to glass contaminationโ€ฆ

 

 

The company, also called Veklury, announced Friday it was recalling two lots of Remdesivir after receiving a customer complaint that led to an investigation which showed glass particulates in vials.

 

Company spokesperson Chris Ridley told Bloomberg News that 55,000 vials were under recall.

 

The drug treatment is used for coronavirus patients in the hospital and is โ€œdistributed in single dose clear glass vials in powder form and reconstituted at the site of use.โ€

 

Gilead said the effects of the glass particulates could be as mild as local irritation or swelling or as severe as blocking blood vessels in the heart, brain or lungs that could lead to a stroke or death. No severe reactions have been reported from the affected vials.

 

https://thehill.com/policy/healthcare/584340-vials-of-drug-used-to-treat-coronavirus-remdesivir-recalled-by-gilead-due?utm_source=thehill&utm_medium=widgets&utm_campaign=es_recommended_content

Anonymous ID: 744b4d Dec. 4, 2021, 9:03 a.m. No.15134530   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>4676 >>4826 >>4912

NEW YORK, Dec 3 (Reuters) - The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations bypicking up a snippet of genetic material from another virus - possibly one that causes the common cold- present in the same infected cells, according to researchers.

 

This genetic sequence does not appear in any earlier versions of the coronavirus, called SARS-CoV-2, but is ubiquitous in many other viruses including those that cause the common cold, and also in the human genome, researchers said.

 

By inserting this particular snippet into itself, Omicron might be making itself look "more human," which would help it evade attack by the human immune system, said Venky Soundararajan of Cambridge, Massachusetts-based data analytics firm nference, who led the study posted on Thursday on the website OSF Preprints.

 

This could mean the virus transmits more easily, while only causing mild or asymptomatic disease. Scientists do not yet know whether Omicron is more infectious than other variants, whether it causes more severe disease or whether it will overtake Delta as the most prevalent variant. It may take several weeks to get answers to these questionsโ€ฆ

 

Have we come full circle then?

 

https://www.reuters.com/business/healthcare-pharmaceuticals/omicron-variant-may-have-picked-up-piece-common-cold-virus-2021-12-03/?fbclid=IwAR0zVlNYdnNmFzIykqJ7jVsLYBWy_0qnNdXv6a-ZoT9YIJhS-4rdTKn34g0